0001209191-20-047842.txt : 20200820 0001209191-20-047842.hdr.sgml : 20200820 20200820201721 ACCESSION NUMBER: 0001209191-20-047842 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200818 FILED AS OF DATE: 20200820 DATE AS OF CHANGE: 20200820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Dolca CENTRAL INDEX KEY: 0001768239 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38653 FILM NUMBER: 201121276 MAIL ADDRESS: STREET 1: C/O PRINCIPIA BIOPHARMA INC. STREET 2: 220 E. GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Principia Biopharma Inc. CENTRAL INDEX KEY: 0001510487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263487603 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 220 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 416-7700 MAIL ADDRESS: STREET 1: 220 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-18 0 0001510487 Principia Biopharma Inc. PRNB 0001768239 Thomas Dolca C/O PRINCIPIA BIOPHARMA INC. 220 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 2020-08-18 4 M 0 15000 23.77 A 16826 D Common Stock 2020-08-18 4 S 0 15000 100.00 D 1826 D Employee Stock Option (right to buy) 23.77 2020-08-18 4 M 0 15000 0.00 D 2028-10-22 Common Stock 15000 168057 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The stock option vested and became exercisable as to 25% of the shares subject to the option on October 22, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Christopher Y. Chai, Attorney-in-Fact for Dolca Thomas 2020-08-20